Viewing Protocol Section

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section

Study NCT04811027
Ignite Creation Date: 2024-05-06 @ 3:56 PM
Last Modification Date: 2024-10-26 @ 2:00 PM
Study NCT ID: NCT04811027
Protocol Section: NCT04811027
Start Identification Module Data
Expand Identification Module Data
Brief Title: Combination Study With Eftilagimod Alpha a Soluble LAG-3 Fusion Protein and Pembrolizumab in Patients With Recurrent or Metastatic HNSCC
Official Title: TACTI-003 Two ACTive Immunotherapeutics A Multicenter Open Label Randomized Phase II Trial to Investigate a Soluble LAG-3 Fusion Protein Eftilagimod Alpha Efti IMP321 in Combination With Pembrolizumab PD-1 Antagonist for First Line Treatment of Subjects With Unresectable Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck HNSCC
Acronym: TACTI-003
Organization: Immutep SAS
Organization Class: INDUSTRY
Organization Study ID: TACTI-003
Secondary IDs
Secondary ID Type Domain Link
MK-3475-C34 OTHER None None
2021-000055-39 EUDRACT_NUMBER None None
KEYNOTE-C-34 OTHER Merck Sharp Dohme Corp None
Start Status Module Data
Status Verified Date: 2024-08
Overall Status: ACTIVE_NOT_RECRUITING
Study First Submit Date:
Study First Submit QC Date:
Last Update Submit Date:
Status:
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: Immutep SAS
Lead Sponsor Class: INDUSTRY
Lead Sponsor: Immutep SAS
Start Oversight Module Data
Description Module:
Study Last Update Post Date Type(Status Module):
Attachment: Upload